Clinical trials
Elderly Patients clinical trials
Below are recruiting elderly patients clinical trials, each written for real people, not researchers. We’re tracking 212 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06469437Recruiting
Geriatric check for older adults with type 2 diabetes
This study looks at how a full health check for older adults with type 2 diabetes can help doctors choose the best treatment plan. It aims to improve care for people 60 and older.
Porto Alegre, Rio Grande do SulAges 60 years+ - NCT06002113Recruiting
Helping older patients share their care goals
This study helps elderly patients (80 or older) in the hospital talk about their wishes for life-sustaining treatments. It aims to make sure your care matches what matters most to you.
Barrie, OntarioAges 80 years+ - NCT07309965Recruiting
Vibration therapy for healing after hip fracture in seniors
This study tests if adding gentle vibration to standard rehab helps older adults recover better after hip fracture surgery. You may qualify if you are 75 or older and recently had surgery for a broken hip.
LyonAges 75 years+ - NCT07030673Recruiting
Stopping antibiotics early in older adults with viral infections
This trial tests whether elderly patients hospitalized with a viral lower respiratory infection can safely stop antibiotics early. It aims to reduce unnecessary antibiotic use and side effects.
AmiensAges 65 years+ - NCT06202118Recruiting
Alpha radiation therapy for breast cancer in older or frail patients
This trial tests a new type of radiation therapy (DaRT) that uses tiny, implantable seeds to deliver targeted alpha radiation to breast tumors. It is designed for older patients (65+) or those who are too frail for surgery, offering a less invasive option for controlling the cancer.
JerusalemAges 65–120 - NCT06946602Recruiting
Study of transplant preparation for older adults with AML
This trial tests a special preparation (conditioning) regimen for patients 55 or older with acute myeloid leukemia (AML) who are in first remission and receiving a half-matched (haploidentical) stem cell transplant. It aims to make the transplant safer and more effective for this age group.
BeijingAges 55 years+ - NCT07314762Recruiting
Support for elderly patients before, during, and after surgery
This trial looks at how to better care for older adults (65+) who are having surgery. It aims to improve their experience and recovery during the time leading up to, during, and after their procedure.
Wenzhou, ZhejiangAges 65 years+ - NCT06954857Recruiting
Laryngeal mask placement in elderly patients
This trial tests a new way to place a breathing tube (laryngeal mask) using pressure monitoring to reduce side effects in older patients during surgery. It may help if you are 60 or older and having planned surgery that lasts 30 minutes to 2 hours.
Chongqing, Chongqing MunicipalityAges 60 years+ - NCT06768125Enrolling by invitation
Shorter radiation therapy for head and neck cancer in older adults
This trial tests a shorter course of radiation therapy for patients aged 65 and older with head and neck cancer who cannot have surgery or standard radiation. The goal is to find an effective and more convenient treatment option.
Beijing, Beijing MunicipalityAges 65 years+ - NCT07424690Recruiting
Comparing ablation with medication care for older adults with atrial fibrillation
This study compares two approaches for older adults with atrial fibrillation: a procedure called catheter ablation (which uses heat or cold to fix the heart's rhythm) versus conservative care (medications and lifestyle changes). The goal is to see which approach is better for improving quality of life and reducing symptoms in people aged 78 and above.
LinköpingAges 78 years+ - NCT07363941Recruiting
Comparing height-based vs standard spinal anesthesia dosing for older adults
This study compares two ways of giving spinal anesthesia (numbing medication in the back) for older adults having leg or hip surgery. It aims to see if adjusting the dose based on height works better than the standard fixed dose. If you are between 60 and 80 and having planned lower limb surgery, you may be eligible.
Karachi, SindhAges 60–80 - NCT05842928Recruiting
Deprescribing risky medicines in older adults with many medications
This study tests a patient-centered plan to safely reduce certain medicines that may cause side effects in older people who take many drugs. It aims to improve safety and comfort by lowering unnecessary use while keeping you well.
BielefeldAges 65 years+ - NCT07514936RecruitingPhase 3
Venetoclax-Azacitidine With Chidamide and CAG for Older AML Patients
This trial tests a combination of four drugs (venetoclax, azacitidine, chidamide, and CAG chemotherapy) to treat newly diagnosed acute myeloid leukemia (AML—a blood cancer) in adults aged 60–75. The goal is to see if this combination helps patients live longer and feel better.
Beijing, None SelectedAges 60–75 - NCT07208500Recruiting
Arm cuff treatment before surgery to protect lungs in older adults
This study tests if a simple, non-invasive treatment (briefly inflating a blood pressure cuff on your arm) before surgery can reduce lung complications in older adults having non-heart, non-lung surgery. It may help protect your lungs during and after the operation.
ShanghaiAges 65 years+ - NCT05814328Recruiting
Care plan after ER visit to prevent early readmissions
This study tests a “transitional care” plan for people over 75 after they leave the emergency room, aiming to reduce how soon they come back. It may help you get the right support at home and lower the risk of returning to the ER quickly.
ParisAges 75 years+ - NCT07839247RecruitingPhase 2
Two oral drugs for brain lymphoma in older adults
This trial tests a combination of two oral medications (zanubrutinib and lenalidomide) for older adults with a certain type of brain lymphoma. The goal is to see if this treatment can help control the disease with manageable side effects.
Beijing, Beijing MunicipalityAges 70 years+ - NCT06990321RecruitingPhase 3
Cytarabine and venetoclax for older adults with AML
This trial tests a combination of two chemotherapy drugs, medium-dose cytarabine and venetoclax, as a follow-up treatment (consolidation) to keep leukemia from coming back. It is for older adults with intermediate or high-risk acute myeloid leukemia who have already achieved remission after their first round of therapy.
Changchun, JilinAges 60–75 - NCT07394959Recruiting
Guided hydration to protect kidneys in elderly heart patients
This trial tests a new way to manage fluids during heart procedures to prevent kidney injury. It uses a special vest that measures lung fluid to guide how much hydration you get.
Beijing, Beijing MunicipalityAges 60 years+ - NCT03711110Recruiting
Heart-protection plan for older people with certain cancers
This trial looks at strategies to help prevent heart and blood-vessel problems in people over 65 who have certain cancers. It may help by monitoring and treating heart risks early to lower the chance of future cardiovascular events.
Santiago de Compostela, A CoruñaAges 65 years+ - NCT04157569Recruiting
Study blood DNA markers after chemotherapy in older acute leukemia
This trial checks a blood test called “ctDNA” (tiny pieces of leukemia DNA in blood) after chemotherapy. It may help doctors understand how well treatment is working in older adults with acute leukemia.
BeijingAges 60–100 - NCT02836158RecruitingPhase 2/Phase 3
Test drug plus spinal chemotherapy for older PCNSL
This trial studies whether adding R-IDARAM and medication delivered into the spinal fluid can improve treatment for primary central nervous system lymphoma (PCNSL) in newly diagnosed older adults. It may help by targeting lymphoma cells in the brain, covering membranes, and spinal fluid.
Beijing, Beijing MunicipalityAges 60–75 - NCT04519905Recruiting
Testing two ways of radiation in older esophagus cancer patients
This study compares a planned radiation approach given at the same time as other treatment for older adults with esophageal squamous cell carcinoma. It may help find a safer and more effective radiation schedule for people who are fit enough for treatment.
Nanjing, JiangsuAges 76 years+ - NCT05459597Recruiting
Testing seizure medicine in older adults
This trial studies how seizure (epilepsy) medicines work in people age 65 and older. If you have epilepsy and are already taking seizure medication, you may be able to join to help researchers learn what to expect from these treatments in older adults.
Jinan, ShandongAges 65–100 - NCT05467189Recruiting
Testing anti-cancer drugs in people age 65 and older
This study looks at how anti-cancer (chemotherapy) drugs are used in adults age 65+ who have cancer. It may help doctors understand which treatments work best and are safest for older adults.
Jinan, ShandongAges 65–100
Hear when a new Elderly Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for elderly patients?
- Yes. Clin2 currently lists 212 recruiting elderly patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a elderly patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a elderly patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.